Replies to post #94312 on Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

Well, in this case, there is no one in whose name GC was speaking. As you note, MJFF did publicly chastise AMBS for the Nov 2012 PR release.

Here you would see it in the LACK of response to offers of JV and what not. It really does not matter what anyone here thinks. The numbers speak for themselves.

The Sen and Spec of Lympro are NOT in the 90s. When you look at differentiating AD patients from demented patients who do not have AD the numbers are in the 90s. That is helpful, as are the current overall numbers for Lympro, which are in the 80s.

See the post down the list a little ways for the links.